The National Institutes of Health proposed a new policy Dec. 3 that would require multi-site studies it funds to only go through a single institutional review board rather than multiple, local IRB reviews, except in special cases.
When human subject protections were first put in place, most clinical research was conducted at a single institution, the agency...